This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.
View our privacy policy to learn more.
OK
Search Options
Join SITC
Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
Educational & Scientific Programs
ConnectED
Advances in Cancer Immunotherapy™
Collaborative Education Programs
2023 Spring Scientific
Workshops
Tumor Immune Microenvironment: A Holistic Approach
Surfaceome Virtual Workshop
Bispecific T cell Engagers Virtual Workshop
Cytokines in Cancer Immunotherapy Virtual Workshop
Call for Proposals
Annual Meeting & Pre-Conference Programs
37th Annual Meeting & Pre-Conference Programs
Past and Future Annual Meetings & Pre-Conference Programs
Cancer Immunotherapy Winter School
Patient and Survivor Education and Resources
Webinars and Online Education
ACI Online Interactive Courses
Advances in Cancer Immunotherapy (ACI) Webinars
Meet-the-Expert Webinars
SITC Clinical Practice Guidelines Online Education
SITC-NCI Computational IO Series
Targets for Cancer IO: A Deep Dive Series
Calendar of Events
Professional Development & Training
Certificate in Cancer Immunotherapy
Meet-the-Expert Program
Meet-the-Expert Webinars
NCI Immunotherapy Fellowship
SITC Sparkathon
SITC Sparkathon 2.0 Accelerator
Support Sparkathon
Other Resources
Calendar of Events
Path to SITC Leadership
Clinical Trials Training and Resources
SITC Clinical Immuno-Oncology Network (SCION) Workshop
Maximizing the Value of Phase III Trials in Immuno-Oncology
Professional Interest Communities
Fellowships
Women in Cancer Immunotherapy Network (WIN)
Women in Cancer Immunotherapy Network 2022
Women in SITC Community
Early Career Scientist (ECS) Committee
Publications & Guidelines
Journal for ImmunoTherapy of Cancer
About JITC
Become a Reviewer
For Authors
From the Editors
JITC Collections and Special Issues
SITC Immunotherapy Books
SITC's Guide to Managing Immunotherapy Toxicity Textbook
Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
SITC Clinical Practice Guidelines
Clinical Practice Guidelines
Clinical Practice Guidelines Online Education
Clinical Practice Guidelines Mobile App
Patient Resource Guides
Policy & Advocacy
Advocacy
Crisis in Clinical Research
Global Immunotherapy Access
Government Relations
Quality and Value
Patient & Survivor Education & Resources
Membership
Academy of Immuno-Oncology
About the Academy
Nomination and Selection
Members Only
SITC Member Directory
Renew Your Membership
Become a SITC Member
Membership Benefits
Submit an Application
Membership Categories
Volunteer
Volunteer with SITC
Connect-a-Colleague
Corporate Membership
Path to SITC Leadership
Support SITC
The Forward Fund
Moving the Field Forward
Making a Difference
Named Funds and Awards
Early Career Scientist Awards
Richard V. Smalley Memorial Award and Lectureship
Steven A. Rosenberg Scholars Award
Technology Awards
Martin "Mac" Cheever Travel Award Fund
Sparkathon 2.0 Accelerator
The CheckPoints: SITC’s House Band
Ways to Make a Gift
Donate
Stocks and Securities
Estate and Planned Gifts
Corporate Support and Giving Opportunities
Corporate Giving Opportunities
Corporate Membership
Educational Grants
Sponsorship & Advertising
SITC Merchandise
Honor and Memorial Gifts
Make a Gift in Honor of a Loved One
Make a Gift in Memory of a Loved One
Our Donors and Supporters
2022 SITC Supporters
Forward
Fund Donors
About SITC
Awards and Recognition
Committees, Task Forces and Professional Interest Communities
Partnerships
SITC Policies
Board of Directors
Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
Media Room
SITC Press Releases
Scientific Meeting Highlights from SITC
Immune Monitor Archive
JITC Digest Archive
Cancer Immunotherapy Month
Career Connections
Mission & Vision
Contact SITC
SITC Staff
Contact Us
The Connect Community
Create Account
My Profile
My Communities
My Libraries
The Sentinel - SITC Blog
2020 SITC Press Releases
Press Release Headline – Date Published
SITC Publishes Clinical Practice Guideline on Immune Effector Cell-related Adverse Events
– 12/18/20
SITC Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Acute Leukemia
– 11/17/20
Society for Immunotherapy of Cancer Announces Creation of Steven A. Rosenberg, MD, PhD, Endowed Scholars Fund and Names Inaugural Recipient
Society for Immunotherapy of Cancer to Host Third Annual Cancer Immunotherapy Winter School
Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Multiple Myeloma
–
8/3/20
Oncology News Burst from FDA: Atezolizumab
–
7/31/20
Oncology News Burst from FDA: Avelumab
–
7/1/20
Oncology News Burst from FDA: Pembrolizumab
–
6/30/20
Oncology News Burst from FDA: Pembrolizumab
–
6/24/20
Oncology News Burst from FDA: Pembrolizumab
–
6/17/20
Oncology News Burst from FDA: Gemtuzumab Ozogamicin
–
6/16/20
Oncology News Burst from FDA: Nivolumab
–
6/11/20
Society for Immunotherapy of Cancer Announces Recipients of 2020 Cancer Immunotherapy Fellowships and Award
–
6/1/20
Oncology News Burst from FDA: Atezolizumab plus Bevacizumab
–
6/1/20
Society for Immunotherapy of Cancer Celebrates Cancer Immunotherapy Month™
– 6/1/20
Oncology News Burst from FDA: Nivolumab plus Ipilimumab
–
5/27/20
Oncology News Burst from FDA: Atezolizumab
– 5/19/20
Oncology News Burst from FDA: Nivolumab plus Ipilimumab
– 5/15/20
Oncology News Burst from FDA: Daratumumab and Hyaluronidase-fihj
– 5/1/20
Oncology News Burst from FDA: Pembrolizumab
– 4/29/20
SITC Announces Three Recipients of the 2020 Richard V. Smalley, MD, Memorial Award and Lectureship
– 4/23/20
Oncology News Burst from FDA: Sacituzumab Govitecan-hziy
– 4/22/2020
Oncology News Burst from FDA: Ibrutinib
– 4/21/2020
Society for Immunotherapy of Cancer Releases Perspective Paper on Investigational Therapies for COVID-19 Patients with Severe Inflammatory Resonse
– 4/21/2020
Oncology News Burst from FDA: Durvalumb
– 3/30/2020
Society for Immunotherapy of Cancer Advocates for Expanded Access to Anti-IL-6 Therapies for Critically Ill Patients
– 3/25/20
Society for Immunotherapy of Cancer urges scientific journals to grant open access to COVID-19 publications
– 3/23/20
Coronavirus (COVID-19) Update: FDA Issues Guidance for Conducting Clinical Trials
– 3/20/20
Oncology News Burst from FDA: Nivolumab and Ipilimumab Combination
– 3/11/20
Oncology News Burst from FDA: Isatuximab-Irfc
– 3/2/20
SITC to Host Leadership Institute Focusing on Professional Development of Women in Cancer Immunotherapy
– 1/27/20
Oncology News Burst from FDA: Pembrolizumab
– 1/8/20
Return
Return to SITC Press Releases home
Membership Links
Join
Renew
Member Directory
My Profile
Get Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2022 Society for Immunotherapy of Cancer (SITC). All rights reserved.
Powered by Higher Logic